Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults

Main Article Content

V. Kvedariene
B. Sitkauskiene
L. Tamasauskiene
O. Rudzeviciene
V. Kasiulevicius
G. Nekrosyte
E.R. Gomes
P. Demoly

Keywords

Drug allergy, Drug hypersensitivity reaction, Prevalence, Self-reported risk factor

Abstract

Introduction and objectives: Drug hypersensitivity reactions (DHRs) are the adverse effects of drugs that, when taken at doses generally tolerated by normal subjects, clinically resemble allergy. We aimed to assess the prevalence of self-reported DHRs among Lithuanian children and adults and to identify possible risk factors.


Materials and methods: A cross-sectional survey of a population visiting their general practitioners in Vilnius and Kaunas regions of Lithuania was performed. Thirty-five questions on drug allergy symptoms, in addition, food, pollen allergy and family history were included.


Results: 3222 (60.0%) children and 2148 (40.0%) adults were included in the study. 7.9% of children and 13.8% of adults reported a DHR for at least one drug (p < 0.001). 69.8% of children and 47.3% of adults, who indicated DHRs, had skin symptoms. Rate of anaphylaxis was similar in both groups (about 10%). 4.5% of children and 7.3% of adults had DHRs induced by antibiotics and this was the most implicated group of drugs. Significant self-reported risk factors for DHRs were family history of DHRs (OR = 6.007, 95%CI 4.756-7.587), pollen allergy (OR = 2.0, 95%CI 1.573-2.544), food allergy (OR = 1.92, 95%CI 1.505-2.448), female gender (OR = 1.439, 95%CI 1.187-1.744) and age (OR = 1.017 in favour of adults, 95%CI 1.013-1.021).


Conclusions: The prevalence of self-reported DHRs in Lithuania is higher among adults than children. Drug-induced skin reactions were the predominant symptom in both groups. Besides female gender and age, a positive family history of DHR and presence of pollen or food allergy may be associated with DHR.

Abstract 117 | PDF Downloads 90

References

1. Demoly P, Adkinson NF, Brockow K, Broide FD. International consensus on drug allergy. Allergy. 2014;69:420-37.

2. Holgate ST, Church MK, Broide DH, Martinez FD. Allergy. 4th ed. Philadelphia: Saunders; 2012.

3. Edwards R, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-9.

4. Demoly P, Viola M, Gomes ER, Romano A. Epidemiology and causes of drug hypersensitivity. In: Pichler WJ, editor. Drug hypersensitivity. Karger: Basel; 2007. p. 2-17.

5. Blumenthal KG, Li Y, Banerji A, Yun BJ, Long AA, Walensky RP. The cost of penicillin allergy evaluation. J Allergy Clin Immunol Pract. 2018;6, 1019-1027.e2.

6. Thong BY-H, Tan T-C. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71:684-700.

7. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122: 778.

8. Gomes E, Cardoso MF, Praca F, Gomes L, Marino˜ E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy. 2004;34:1597-601.

9. Kurt E, Demir AU, Cadirci O, Yildirim H, Pinar Eser T. Immediate type drug hypersensitivity and associated factors in a general population. Allergol Immunopathol (Madr). 2011;39: 27-31.

10. Bedolla-Barajas M, Puente-Fernandez C, Flores-Merino MV, Morales-Romero J, Dominguez-Garcia MV. Self-report prevalence and associated factors to drug hypersensitivity in Mexican young adults. Asia Pac Allergy. 2017;7:156-62.

11. Bavbek S, Erkekol FÖ, Celik GE, Gönüllü I, Misirligil Z. Self-reported prevalence of hypersensitivity reactions against drugs among medical students: does awareness cause any difference? Pharmacoepidemiol Drug Saf. 2011;20:154-61.

12. Zilinskaite˙ L, Tamasauskas D, Kvedariene V, Sitkauskiene B. Self-reported drug allergy in health care workers in conservative and surgical medicine departments. J Investig Allergol Clin Immunol. 2012;22:357-62.

13. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008;38:191-8.

14. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol. 2008;19:634-8.

15. Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol. 2008;19:82-5.

16. Tan VA, Gerez IF, Van Bever HP. Prevalence of drug allergy in Singaporean children. Singapore Med J. 2009;50: 1158-61.

17. Star K, Norén GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide. An exploratory study using VigiBase. Drug Saf. 2011;34:415-28.

18. Sousa-Pinto B, Fonseca JA, Gomes ER. Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression. Ann Allergy Asthma Immunol. 2017;119, 362-373.e2.

19. Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca Lopez N, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2015;71:149-61.

20. Kvedariene V, Rudzeviciene O, Silkina O, Kavaliauskaite L, Drusyte S, Volugyte I, et al. Hypersensibilite medicamenteuse dans la region de Vilnius Lituanie. Rev Fr Allergol. 2007;47:279.